Brenda Cooperstone
Direttore/Membro del Consiglio presso SENTI BIOSCIENCES, INC.
Patrimonio netto: - $ in data 31/01/2025
Profilo
Dr. Brenda Cooperstone, MD, is an Independent Director at Lexeo Therapeutics, Inc., an Independent Director at Gandeeva Therapeutics, Inc. and an Independent Director at Senti Biosciences, Inc. She is on the Board of Directors at Lexeo Therapeutics, Inc., Gandeeva Therapeutics, Inc., Senti Sub I, Inc. and Senti Biosciences, Inc. Dr. Cooperstone was previously employed as a Chief Development Officer & Senior Vice President by Pfizer Inc. She received her doctorate degree from McGill University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SENTI BIOSCIENCES, INC.
-.--% | 10/07/2024 | 0 ( -.--% ) | - $ | 31/01/2025 |
LEXEO THERAPEUTICS, INC.
-.--% | 25/06/2024 | 0 ( -.--% ) | - $ | 31/01/2025 |
Ultime notizie su Brenda Cooperstone
Posizioni attive di Brenda Cooperstone
Società | Posizione | Inizio |
---|---|---|
SENTI BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/10/2019 |
LEXEO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/08/2023 |
Senti Sub I, Inc.
![]() Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Direttore/Membro del Consiglio | 01/10/2019 |
Gandeeva Therapeutics, Inc.
![]() Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Gandeeva Therapeutics, Inc. is a Canadian company that specializes in drug discovery using a unique approach to develop precision medicines. The company is based in Vancouver, Canada and was founded by Sriram Subramaniam, who has been the CEO since incorporation. The company's focus is on understanding the language by which proteins communicate in vivo, which is fundamental to deciphering biology. The company's discovery process involves identifying the optimal protein-protein interactions and altering protein structures to develop drugs that can treat various diseases. | Direttore/Membro del Consiglio | 23/01/2023 |
Precedenti posizioni note di Brenda Cooperstone
Società | Posizione | Fine |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | 01/12/2022 |
Formazione di Brenda Cooperstone
McGill University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
PFIZER, INC. | Health Technology |
SENTI BIOSCIENCES, INC. | Health Technology |
LEXEO THERAPEUTICS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Senti Sub I, Inc.
![]() Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Gandeeva Therapeutics, Inc.
![]() Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Gandeeva Therapeutics, Inc. is a Canadian company that specializes in drug discovery using a unique approach to develop precision medicines. The company is based in Vancouver, Canada and was founded by Sriram Subramaniam, who has been the CEO since incorporation. The company's focus is on understanding the language by which proteins communicate in vivo, which is fundamental to deciphering biology. The company's discovery process involves identifying the optimal protein-protein interactions and altering protein structures to develop drugs that can treat various diseases. | Commercial Services |
- Borsa valori
- Insiders
- Brenda Cooperstone